Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-119813
Filing Date
2007-05-21
Accepted
2007-05-21 17:21:35
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 592331
2 CONSENT OF SWENSON ADVISORS, LLP dex231.htm EX-23.1 1715
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9189
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9196
5 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 5272
  Complete submission text file 0001193125-07-119813.txt   619233
Mailing Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037 8586460789
AKESIS PHARMACEUTICALS, INC. (Filer) CIK: 0001042420 (see all company filings)

EIN.: 841409219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27409 | Film No.: 07868849
SIC: 2834 Pharmaceutical Preparations